Canopy Growth Corp(CGC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,642 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CGC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Canopy Growth Corp (CGC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CGC at 26.0/100 on a 32-signal composite quality model, placing it at rank #2,642 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (8.6) and balance sheet strength (9.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.3/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of CGC by reported 13-F value include Toroso Investments, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, based on the most recent SEC filings. CGC trades on the Nasdaq exchange and files with the SEC under CIK 1737927. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Canopy Growth Corp directly from SEC EDGAR. Canopy Growth Corp's 13F Pro composite quality score has ranged between 21 and 26 since 2026, currently 26.0 — a stable long-term trajectory across 47 quarterly and live scoring snapshots.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+5.8% YoYNet Income
+48.3% YoYOperating Income
-38.0% YoYEPS (Diluted)
+81.4% YoYTotal Assets
+21.9% YoYTotal Debt
-19.0% YoYOp. Cash Flow
+61.5% YoYFree Cash Flow
+60.8% YoY| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $284.6M +5.8% | $269.0M -9.5% | $297.1M -10.8% | $333.3M -29.9% | $475.7M -13.0% | $546.6M |
| Net Income | $-262.9M +48.3% | $-508.9M +26.6% | $-693.7M +78.8% | $-3.28B -957.3% | $-310.0M +82.2% | $-1.74B |
| Operating Income | $-161.7M -38.0% | $-117.1M +48.8% | $-228.7M +91.3% | $-2.63B -158.2% | $-1.02B +18.1% | $-1.24B |
| EPS (Diluted) | $-0.88 +81.4% | $-4.73 +49.0% | $-9.27 +86.9% | $-70.69 -792.6% | $-7.92 -68.9% | $-4.69 |
| Total Assets | $1.12B +21.9% | $917.7M -29.4% | $1.30B -46.7% | $2.44B -56.6% | $5.62B -17.7% | $6.82B |
| Total Debt | $249.6M -19.0% | $308.3M -48.4% | $597.2M -68.0% | $1.86B +24.2% | $1.50B -5.8% | $1.59B |
| Operating Cash Flow | $-63.8M +61.5% | $-165.8M +41.2% | $-281.9M +49.4% | $-557.5M -2.2% | $-545.8M -17.2% | $-465.7M |
| Free Cash Flow | $-69.1M +60.8% | $-176.6M +38.1% | $-285.4M +49.6% | $-566.7M +2.7% | $-582.5M +7.6% | $-630.2M |
Get alerted when CGC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Canopy Growth Corp including:
Top Institutional Holders of CGC
Toroso Investments, LLC
$8.7M9,189,630 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$2.2M2,315,600 shMORGAN STANLEY
$1.8M1,946,294 shLAZARD ASSET MANAGEMENT LLC
$1.8M1,847,500 shGROUP ONE TRADING, L.P.
$1.7M1,744,200 shJANE STREET GROUP, LLC
$1.5M1,562,808 shSIMPLEX TRADING, LLC
$1.3M1,403,500 shUBS Group AG
$1.3M1,396,338 shGOLDMAN SACHS GROUP INC
$1.2M1,303,720 shCITADEL ADVISORS LLC
$1.2M1,254,500 sh
| Fund | Value | Shares |
|---|---|---|
| Toroso Investments, LLC | $8.7M | 9,189,630 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.2M | 2,315,600 |
| MORGAN STANLEY | $1.8M | 1,946,294 |
| LAZARD ASSET MANAGEMENT LLC | $1.8M | 1,847,500 |
| GROUP ONE TRADING, L.P. | $1.7M | 1,744,200 |
| JANE STREET GROUP, LLC | $1.5M | 1,562,808 |
| SIMPLEX TRADING, LLC | $1.3M | 1,403,500 |
| UBS Group AG | $1.3M | 1,396,338 |
| GOLDMAN SACHS GROUP INC | $1.2M | 1,303,720 |
| CITADEL ADVISORS LLC | $1.2M | 1,254,500 |
Companies Similar to CGC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Tilray Brands, Inc.
NOVAVAX INC
Inotiv, Inc.
Nano-X Imaging Ltd.
Xtant Medical Holdings, Inc.
HERON THERAPEUTICS, INC. /DE/
AVANOS MEDICAL, INC.
OPKO HEALTH, INC.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put CGC on your watchlist
Track score changes the day Canopy Growth Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CGC a good stock to buy?
13F Pro's AI-powered analysis of Canopy Growth Corp (CGC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CGC are available on the CGC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CGC is classified as a small company.
Which hedge funds own CGC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CGC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Canopy Growth Corp's investment landscape.